Outset Medical
General Information | |
Business: |
Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. We believe Tablo represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. We designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. Our technology is designed to elevate the dialysis experience for patients, and help providers overcome traditional care delivery challenges. Our relentless focus on flexibility, ease of use and user experience translates to meaningfully reduced training times and fixed infrastructure requirements. |
Industry: | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Employees: | 273 |
Founded: | 2013 |
Contact Information | |
Address | 3052 Orchard Drive, San Jose, CA 95134, US |
Phone Number | (669) 231-8200 |
Web Address | http://www.outsetmedical.com |
View Prospectus: | Outset Medical |
Financial Information | |
Market Cap | $1105.65mil |
Revenues | $28.6 mil (last 12 months) |
Net Income | $-41.1 mil (last 12 months) |
IPO Profile | |
Symbol | OM |
Exchange | NASDAQ |
Shares (millions): | 9.0 |
Price range | $27.00 - $27.00 |
Est. $ Volume | $241.7 mil |
Manager / Joint Managers | BofA Securities/ Morgan Stanley/ Goldman Sachs |
CO-Managers | SVB Leerink/ Stifel |
Expected To Trade: | 9/15/2020 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |